Figure 7.

miR-155 upregulation and SOCS1 silencing promote the cell cycle entry of hepatic stellate cells. (A) Cell cycle progression of differently transfected hepatic stellate cells. (B) Quantitative analysis of cell cycle rate in transfected cells. *p < 0.05 vs. normal hepatic stellate cells, ^# p < 0.05 vs. cells without any treatment and cells treated with miR-155 NC. The measurement data are expressed as mean ± standard deviation. Data comparisons between different groups were performed by using one-way ANOVA, with Tukey’s post-hoc test for backtesting. Cell experiments were repeated three times. ANOVA, analysis of variance.